Tango Therapeutics, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue0053.8M3.2M5.4M4.1M11.6M19.9M
Cost of Goods Sold463K479K0625K0000
Gross Profit-463K-479K53.8M2.6M5.4M4.1M11.6M19.9M
R&D Expenses33.1M33.3M30.8M32.2M36.4M33.9M33.3M38.7M
Operating Expenses48.3M41.4M39.7M43.5M47.9M45.0M44.5M49.4M
Operating Income-48.8M-41.9M14.1M-41.0M-42.5M-40.9M-32.9M-29.6M
Other Income / Gains3.3M3.1M1.8M2.1M2.7M3.3M3.8M4.1M
Net Income-45.5M-38.7M15.9M-38.9M-39.9M-37.7M-29.2M-25.6M
EPS (Diluted)-0.32-0.300.14-0.35-0.36-0.34-0.27-0.24
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio001.000.8041.001.001.001.00
General And Administrative Expenses15.2M9.8M8.9M11.3M11.5M11.1M11.2M10.8M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses15.2M9.8M8.9M11.3M11.5M11.1M11.2M10.8M
Other Expenses0-1.7M000000
Cost And Expenses48.8M41.9M39.7M44.1M47.9M45.0M44.5M49.4M
Interest Income2.2M1.7M1.1M1.2M1.6M1.8M1.8M2.1M
Interest Expense00000000
Depreciation And Amortization463K479K555K625K622K620K622K632K
Ebitda-45.0M-38.3M16.4M-38.2M-39.2M-37.0M-28.5M-24.9M
Ebitdaratio000.305-12.007-7.274-8.987-2.455-1.251
Operating Income Ratio000.262-12.879-7.888-9.937-2.833-1.487
Income Before Tax-45.5M-38.8M15.9M-38.8M-39.8M-37.6M-29.1M-25.5M
Income Before Tax Ratio000.295-12.203-7.389-9.138-2.508-1.282
Income Tax Expense1K-55K-10K35K34K49K54K65K
Net Income Ratio000.295-12.214-7.395-9.15-2.513-1.286
Epsdiluted-0.32-0.300.14-0.35-0.36-0.34-0.27-0.24
Weighted Average Shs Out143.6M116.2M111.0M110.5M110.3M108.7M108.5M108.3M
Weighted Average Shs Out Dil143.6M116.2M111.0M110.5M110.3M108.7M108.5M108.3M